Generation and characterization of bispecific tandem diabodies for tumor therapy.
Kipriyanov
Sergey M
SM
Affimed Therapeutics AG, Heidelberg, Germany.
D018033:Antibodies, Bispecific / Q000096:biosynthesis / Q000302:isolation & purification / Q000627:therapeutic use*; D000912:Antibodies, Neoplasm / Q000276:immunology; D018941:Antigens, CD19 / Q000276:immunology; D017252:CD3 Complex / Q000276:immunology; D019496:Cancer Vaccines / Q000096:biosynthesis* / Q000302:isolation & purification / Q000627:therapeutic use*; D002460:Cell Line; D004926:Escherichia coli / Q000378:metabolism; D005434:Flow Cytometry / Q000379:methods; D005818:Genetic Engineering / Q000379:methods*; D006801:Humans; D007128:Immunoglobulin Fragments / Q000276:immunology / Q000378:metabolism; D007135:Immunoglobulin Variable Region / Q000235:genetics / Q000276:immunology; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D011485:Protein Binding; D011994:Recombinant Proteins / Q000276:immunology / Q000302:isolation & purification* / Q000378:metabolism
D018033:Antibodies, Bispecific; D000912:Antibodies, Neoplasm; D018941:Antigens, CD19; D017252:CD3 Complex; D019496:Cancer Vaccines; D007128:Immunoglobulin Fragments; D007135:Immunoglobulin Variable Region; D011994:Recombinant Proteins